PATENT CLAIM ANALYSIS

Application Number: 16170764
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
Described herein are pseudotyped oncolytic viruses comprising nucleic acids encoding an engager molecule. In some embodiments, the pseudotyped oncolytic viruses comprises nucleic acids encoding an engager molecule and one or more therapeutic molecules. Pharmaceutical compositions containing the pseudotyped oncolytic virus and methods of treating cancer using the pseudotyped oncolytic viruses are further provided herein.

Claim (Index 18):
The oncolytic HSV of  claim 13 , wherein one or more the HSV glycoproteins are modified to alter the trophism of the oncolytic HSV.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.56757
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15511973', '16132064', '15767076', '15046000', '16161542']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7776088608658104
- 35 USC 102 Novelty (BERT): 0.5199562560681079
- Combined Prediction Score: 0.7518436003860401
- Mean Citation Score: 294.459042
- Max Citation Score: 304.05737
- Similarity Product: 203.35670327316225

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test